Member Info for RichTheNewbie

Also like the concluding paragraph:
‘Based on pricing points for [potential Covid-19 treatments] Rebif and Avonex and Gilead’s remdesivir ($2-3,000 per treatment) and the prospect of Synairgen being able to supply up to 1m doses by the end of 2020, it is not inconceivable that an order book of $2-3bn could be generated by the year-end,’ he said.

Thanks Deal3r - hadn't seen that. It shows the calibre of people buying this whilst PI's sell.

I suspect this just means they start giving it to patients who have COVID now in the UK - that's better than not - after all we have a lot less cases than other places now.
Nothing to stop America authorising it for use though as they've got millions of people desperately in need of a treatment.

And you didn't try to scaremonger a load of sells with absolute bullsh*t. So that makes you better than 90% of the posters ;)
Looking forward to tomorrow after news starts to land around the world.

Because they have the patent on inhaled delivery via nebuliser. Other methods are worse in a large number of ways.

Already answered that earlier:

Vaccine is getting a lot of attention but isn't actually that significant.

To quote The Times' science editor:
"To be clear on this, this is indeed exciting - but this is not proof it works. Now we need results from the field. It is more it would have been catastrophic if it hadn't performed like this at this stage."

Still nowhere near real-world vaccination of millions of people.

Can't I just offer her a brownie....

I don't know whether I'd say "confident" but often it takes a while for news to be digested. Whether that be by serious players making an investment case and executing it - or just the world as a whole waking up to the news reports of a treatment that works for COVID. 99% of people won't have seen the news yet.

Not worried about the share price now....I'm sure this will do well as the news spreads around the world over the next few days.....but how the feck am I going to explain my insobriety when the mrs gets home (without telling her I've made lots of money).

Vaccine is getting a lot of attention but isn't actually that significant.

To quote The Times' science editor:
"To be clear on this, this is indeed exciting - but this is not proof it works. Now we need results from the field. It is more it would have been catastrophic if it hadn't performed like this at this stage."

Still nowhere near real-world vaccination of millions of people.

We’re going to have to chip in and get the SNG team better internet connections for these interviews on national news ;)

You’re welcome Peter.

Anyone buying into a share on the basis of a pump and dump team, like HEMO clearly has, needs their head examining. Avoid that like the plague.
Although if you have the plague....SNG might help....

Of course they have a patent - others have even provided links to the patents.
AstraZeneca were happy to do big deals on the basis of them. So you can either believe some twerp on here trying to get you to sell your shares.....or look at the actual filed patents.....or believe that a global pharma like AstraZeneca would have checked them and considered worth doing massive deals for.
There's no depths they won't go to - in order to try to get people to sell.

Obviously they do. There's a pump and dump crowd on here trying to pump things like HEMO and spreading false information about this share trying to get people to sell. Scum of the earth but not a lot you can do about it.

The 238p resistance level. Lol. You really are a waste of air.

You as well. Scum.

2/3 posters are scaremongering filth and are trying to manipulate people with ill informed posts.
DYOR. Madness.

Add Natham89 to the list of other nasty pieces of work.
It does have a patent you total knob so I guess you're recommending people buy.

Final quick question from the Daily Mail - answered swiftly. So more press there then.